1 withdrawn. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Withdrawn 1 |
Follow Raphael Bueno, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pembrolizumab + Defactinib In Pleural Mesothelioma Pembrolizumab, Defactinib - Malignant Pleural Mesothelioma | Phase 1 | Withdrawn | Raphael Bueno, MD | 2020-09-01 | 2020-11-17 |
defactinib (1) · pembrolizumab (1)
United States (1)